SCHEMBL20122048

SCHEMBL20122048

CC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)C(C)C)C(=O)O)C(=O)O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NOD1 Q9Y239 8/20 0.50
▸ ALDH1A1 P00352 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ THPO P40225 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ FOLH1 Q04609 4/20 0.42
▸ NAALAD2 Q9Y3Q0 2/20 0.42
▸ RIMKLA Q8IXN7 1/20 0.42
▸ GNPAT O15228 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122041 1.00 NOD1 (0.50) NOD1ALDH1A1KDM4EMAPTTHRB
SCHEMBL20122040 0.88 NOD1 (0.46) NOD1ALDH1A1KDM4EMAPTTHRB
SCHEMBL21937061 0.87 NOD1 (0.54) NOD1FOLH1NAALAD2RIMKLAGNPAT
SCHEMBL19704935 0.85 NOD1 (0.64) NOD1GNPAT
SCHEMBL18272425 0.84 FOLH1 (0.60) NOD1ALDH1A1KDM4EMAPTTHRB
SCHEMBL15451406 0.84 NOD1 (0.54) NOD1ALDH1A1KDM4EMAPTTHRB
SCHEMBL14478725 0.84 NOD1 (0.54) NOD1ALDH1A1KDM4EMAPTTHRB
SCHEMBL15451404 0.84 NOD1 (0.54) NOD1ALDH1A1KDM4EMAPTTHRB
SCHEMBL19718595 0.84 FOLH1 (0.60) NOD1ALDH1A1KDM4EMAPTTHRB
SCHEMBL18082026 0.84 FOLH1 (0.60) NOD1ALDH1A1KDM4EMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963496-B2 Stable glucagon analogues and use for treatment of hypoglycaemia NOVO NORDISK A/S (DK) 2018-05-08 — — US disclosed
Send feedback